Skip to main content

GTG Reaches Settlement with One Lambda

NEW YORK (GenomeWeb News) – Genetic Technologies today announced it has executed a Covenant Not to Sue and Release agreement with transplant diagnostics firm One Lambda.

The terms of the agreement were not disclosed, and Genetic Technologies did not elaborate on the nature of its dispute with One Lambda, based in Canoga Park, Calif. Last week, the Australian firm, which has sued numerous firms claiming infringement of its non-coding DNA technology, announced four such lawsuits.

Thermo Fisher Scientific acquired One Lambda for $925 million a month ago.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.